Alamar Biosciences Ownership | Who Owns Alamar Biosciences?
Alamar Biosciences Ownership Summary
Alamar Biosciences is owned by 35.33% institutional investors, 26.64% insiders, and 38.02% retail investors. Sands capital ventures is the largest institutional shareholder, holding 6.10% of ALMR shares. T. Rowe Price Small-Cap Stock is the top mutual fund, with 1.41% of its assets in Alamar Biosciences shares.
ALMR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Alamar Biosciences | 35.33% | 26.64% | 38.02% |
| Sector | Healthcare Stocks | 245.07% | 12.10% | -157.17% |
| Industry | Biotech Stocks | 380.48% | 11.73% | -292.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Sands capital ventures | 4.23M | 6.10% | $114.62M |
| Samsara biocapital | 2.48M | 3.58% | $67.19M |
| T. rowe price investment management | 2.20M | 3.18% | $59.67M |
| Ark investment management | 1.37M | 1.98% | $37.22M |
| Braidwell lp | 1.08M | 1.56% | $29.37M |
| Alliancebernstein | 1.00M | 1.45% | $27.17M |
| Hhlr advisors | 956.46K | 1.38% | $25.91M |
| Blackrock funding, inc. /de | 911.45K | 1.31% | $24.69M |
| Millennium management | 865.76K | 1.25% | $23.45M |
| Fmr | 829.42K | 1.20% | $22.47M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pura vida investments | 755.91K | 55.35% | $20.48M |
| Sands capital ventures | 4.23M | 18.68% | $114.62M |
| Samsara biocapital | 2.48M | 5.52% | $67.19M |
| Hhlr advisors | 956.46K | 3.11% | $25.91M |
| Braidwell lp | 1.08M | 1.09% | $29.37M |
| Avidity partners management lp | 110.00K | 0.48% | $2.98M |
| Emerald advisers | 647.18K | 0.41% | $17.53M |
| Emerald mutual fund advisers trust | 422.13K | 0.40% | $11.44M |
| Ark investment management | 1.37M | 0.24% | $37.22M |
| Deerfield management company, l.p. (series c) | 600.00K | 0.17% | $16.25M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sands capital ventures | 4.23M | 18.68% | 4.23M |
| Samsara biocapital | 2.48M | 5.52% | 2.48M |
| T. rowe price investment management | 2.20M | 0.04% | 2.20M |
| Ark investment management | 1.37M | 0.24% | 1.37M |
| Braidwell lp | 1.08M | 1.09% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sbi securities | 2.00 | - | 2.00 |
| North star investment management | 100.00 | 0.00% | 100.00 |
| Sterling capital management | 115.00 | 0.00% | 115.00 |
| Tower research capital llc (trc) | 248.00 | 0.00% | 248.00 |
| Newedge advisors | 440.00 | - | 440.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sands capital ventures | 4.23M | 18.68% | 4.23M | $114.62M |
| Samsara biocapital | 2.48M | 5.52% | 2.48M | $67.19M |
| T. rowe price investment management | 2.20M | 0.04% | 2.20M | $59.67M |
| Ark investment management | 1.37M | 0.24% | 1.37M | $37.22M |
| Braidwell lp | 1.08M | 1.09% | 1.08M | $29.37M |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 86 | - | 24,489,706 | - | 35 | - | 86 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Small-Cap Stock | 978.66K | 1.41% | -133.00 |
| ARK Genomic Revolution ETF | 957.18K | 1.38% | -20.16K |
| ARK Genomic Revolution | 667.24K | 0.96% | 667.24K |
| T. Rowe Price Instl Small-Cap Stock | 532.30K | 0.77% | - |
| ARK Venture D | 531.79K | 0.77% | 531.79K |
| AB Small Cap Growth A | 445.30K | 0.64% | 14.91K |
| T. Rowe Price US Small-Cap Core Equity | 355.86K | 0.51% | 355.86K |
| Columbia Small Cap Growth Inst | 345.77K | 0.50% | - |
| Columbia Small Cap Growth | 345.77K | 0.50% | 345.77K |
| Principal SmallCap Growth I Instl | 321.12K | 0.46% | 24.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 20, 2026 | Illumina Innovation Fund II GP, L.L.C. | - | Buy | $4.00M |
| Apr 20, 2026 | Naclerio Nicholas | - | Buy | $4.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | - |
| 2026 Q2 | 2 | - |
ALMR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools